SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-17-163318
Filing Date
2017-05-09
Accepted
2017-05-09 06:10:22
Documents
49
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d373504d10q.htm 10-Q 560434
2 EX-10.1 d373504dex101.htm EX-10.1 24778
3 EX-31.1 d373504dex311.htm EX-31.1 9085
4 EX-31.2 d373504dex312.htm EX-31.2 9074
5 EX-32.1 d373504dex321.htm EX-32.1 5279
  Complete submission text file 0001193125-17-163318.txt   2407708

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT aqxp-20170331.xml EX-101.INS 375774
7 XBRL TAXONOMY EXTENSION SCHEMA aqxp-20170331.xsd EX-101.SCH 27234
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aqxp-20170331_cal.xml EX-101.CAL 38546
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aqxp-20170331_def.xml EX-101.DEF 69676
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE aqxp-20170331_lab.xml EX-101.LAB 222940
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aqxp-20170331_pre.xml EX-101.PRE 152889
Mailing Address 887 GREAT NORTHERN WAY SUITE 450 VANCOUVER A1 V5T 4T5
Business Address 887 GREAT NORTHERN WAY SUITE 450 VANCOUVER A1 V5T 4T5 604-629-9223
AQUINOX PHARMACEUTICALS, INC (Filer) CIK: 0001404644 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36327 | Film No.: 17824336
SIC: 2834 Pharmaceutical Preparations